Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SCP Private Credit Income BDC LLCNONE · Entity 114847 | Director | August 28, 2018 | August 28, 2018 |
| SLR HC BDC LLCN/A · Entity 114848 | Director | March 30, 2021 | March 30, 2021 |
| SLR Investment Corp.SLRC · Entity 5226 | Director | November 16, 2022 | May 24, 2023 |
| SLR Private Credit BDC II LLCN/A · Entity 114885 | Director | April 03, 2023 | April 03, 2023 |
| SLR Secured Specialty Lending FundN/A · Entity 184330 | Director | September 12, 2026 | October 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SCP Private Credit Income BDC LLC
Report date August 28, 2018 · Filed August 28, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| UnitsSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2018-08-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
SLR HC BDC LLC
Report date March 30, 2021 · Filed March 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| UnitsSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2021-03-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
SLR Investment Corp.
Report date November 16, 2022 · Filed May 24, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,742 |
Reported balance
After 2022-11-16 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2022-11-16 · Sale · Disposed 3,000 · Balance 2,742 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reported price for the share sales made on November 16, 2022 is based on prices ranging from a low of $13.9700 per share to a high of $14.0700 per share. The reporting person undertakes to provide to SLR Investment Corp. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth above. F2: This amendment to the Form 4 filed on November 18, 2022 is being filed to remove the disclosure of 19,258 shares of common stock of the Issuer that are held by an entity for which the reporting person is a managing trustee. Such shares were previously included in the Form 4 filed on November 18, 2022 by the reporting person but were not required to be included in the Form 4 filed on November 18, 2022 because the reporting person has no pecuniary interest in the 19,258 shares held by the entity for which the reporting person is a managing trustee. The reporting person is not deemed the beneficial owner of the securities held by this entity and does not need to report the securities held by this entity on his beneficial ownership reports. No other changes are being made hereby. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reported price for the share sales made on November 16, 2022 is based on prices ranging from a low of $13.9700 per share to a high of $14.0700 per share. The reporting person undertakes to provide to SLR Investment Corp. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth above.
F2: This amendment to the Form 4 filed on November 18, 2022 is being filed to remove the disclosure of 19,258 shares of common stock of the Issuer that are held by an entity for which the reporting person is a managing trustee. Such shares were previously included in the Form 4 filed on November 18, 2022 by the reporting person but were not required to be included in the Form 4 filed on November 18, 2022 because the reporting person has no pecuniary interest in the 19,258 shares held by the entity for which the reporting person is a managing trustee. The reporting person is not deemed the beneficial owner of the securities held by this entity and does not need to report the securities held by this entity on his beneficial ownership reports. No other changes are being made hereby.
SLR Private Credit BDC II LLC
Report date April 03, 2023 · Filed April 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| UnitsSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2023-04-03 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
SLR Secured Specialty Lending Fund
Report date September 12, 2026 · Filed October 09, 2026
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (4)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AdaptHealth Corp.
Report date November 08, 2019 · Filed November 13, 2019
Section 16 reporting ended · disclosed 2019-11-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 20,000 |
Reported balance
After 2019-11-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-11-08 · Other · Disposed 6,087 · Balance 20,000 F1: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, Steven Hochberg transferred to AdaptHealth Holdings, LLC and certain of its equityholders and employees shares of the Issuer's common stock for no consideration. F2: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 3,672,500 |
Reported balance
After 2019-11-08 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-11-08 · Other · Disposed 2,373,152 · Balance 3,672,500 F3: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F4: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. |
| Private Placement WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2024-11-08 | IndirectSee Footnote | 2,643,333 |
Reported balance
After 2019-11-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-11-08 · Other · Disposed 1,690,000 · Balance 2,643,333 F3: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F4: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, Steven Hochberg transferred to AdaptHealth Holdings, LLC and certain of its equityholders and employees shares of the Issuer's common stock for no consideration.
F2: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P.
F3: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration.
F4: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.
CareMax, Inc.
Report date February 11, 2022 · Filed February 15, 2022
Section 16 reporting ended · disclosed 2022-02-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | IndirectThrough DFHTA Sponsor LLC | 0 |
Reported balance
After 2022-02-11 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2022-02-11 · Other · Disposed 3,768,750 · Balance 0 F1: On February 11, 2022, DFHTA Sponsor LLC (the "Sponsor") distributed 3,768,750 shares of the Issuer's Class A common stock and 2,916,667 Private Placement Warrants to its members, on a pro rata basis for no consideration, in connection with the dissolution of the Sponsor. F2: The Sponsor was the record holder of the securities reported herein as being held through the Sponsor. Mr. Hochberg is a manager of the Sponsor and shared voting and investment discretion with respect to the common stock held of record by the Sponsor. Mr. Hochberg disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein, if any. |
| Private Placement WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2026-06-08 | IndirectThrough DFHTA Sponsor LLC | 0 |
Reported balance
After 2022-02-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-11 · Other · Disposed 2,916,667 · Balance 0 F1: On February 11, 2022, DFHTA Sponsor LLC (the "Sponsor") distributed 3,768,750 shares of the Issuer's Class A common stock and 2,916,667 Private Placement Warrants to its members, on a pro rata basis for no consideration, in connection with the dissolution of the Sponsor. F2: The Sponsor was the record holder of the securities reported herein as being held through the Sponsor. Mr. Hochberg is a manager of the Sponsor and shared voting and investment discretion with respect to the common stock held of record by the Sponsor. Mr. Hochberg disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein, if any. |
| Class A common stockSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2022-02-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 50,000 F3: Mr. Hochberg, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 11, 2022, DFHTA Sponsor LLC (the "Sponsor") distributed 3,768,750 shares of the Issuer's Class A common stock and 2,916,667 Private Placement Warrants to its members, on a pro rata basis for no consideration, in connection with the dissolution of the Sponsor.
F2: The Sponsor was the record holder of the securities reported herein as being held through the Sponsor. Mr. Hochberg is a manager of the Sponsor and shared voting and investment discretion with respect to the common stock held of record by the Sponsor. Mr. Hochberg disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein, if any.
F3: Mr. Hochberg, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P.
SLR Senior Investment Corp.
Report date April 01, 2022 · Filed April 05, 2022
Section 16 reporting ended · disclosed 2022-04-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-04-01 transaction · row 1
1 source rowRow 1 · 2022-04-01 · Disposition to issuer · Disposed 20,000 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of December 1, 2021 (the "Merger Agreement"), by and among SLR Investment Corp. ("SLRC"), SLR Senior Investment Corp. ("SUNS"), Solstice Merger Sub, Inc. and SLR Capital Partners, LLC (for the limited purposes set forth therein), in exchange for 15,592 shares of common stock, par value $0.01 per share, of SLRC. Pursuant to the Merger Agreement, each share of SUNS's common stock, par value $0.01 per share, was converted into the right to receive 0.7796 shares of SLRC's common stock. The disposition reported in this Form 4 is an exempt transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger, dated as of December 1, 2021 (the "Merger Agreement"), by and among SLR Investment Corp. ("SLRC"), SLR Senior Investment Corp. ("SUNS"), Solstice Merger Sub, Inc. and SLR Capital Partners, LLC (for the limited purposes set forth therein), in exchange for 15,592 shares of common stock, par value $0.01 per share, of SLRC. Pursuant to the Merger Agreement, each share of SUNS's common stock, par value $0.01 per share, was converted into the right to receive 0.7796 shares of SLRC's common stock. The disposition reported in this Form 4 is an exempt transaction.
Starling Oncology, Inc.
Report date November 12, 2021 · Filed November 16, 2021
Jointly reported with DFP Sponsor LLC, Atinsky Lawrence
Section 16 reporting ended · disclosed 2021-11-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 40 |
Reported balance
After 2021-11-12 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-11-12 · Conversion · Acquired 40 · Balance 40 F1: Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration. F2: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor. F3: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 40 |
Reported balance
After 2021-11-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-11-12 · Other · Disposed 707,960 · Balance 40 F4: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date. F5: In connection with, and immediately prior to, the closing of the Issuer's initial business combination, pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, the Sponsor forfeited 707,960 shares of Class B Common Stock for no consideration. F2: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor. F3: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
| Class B Common StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-11-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-11-12 · Conversion · Disposed 40 · Balance 0 F4: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date. F1: Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration. F2: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor. F3: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
| Private Placement WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2026-11-12 | Direct | 3,177,543 |
Reported balance
After 2021-11-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-11-12 · Other · Acquired 3,177,543 · Balance 3,177,543 F6: The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%. F2: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor. F3: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise. |
Filing footnotes · ownership attribution and instrument terms
F1: Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration.
F2: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor.
F3: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise.
F4: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date.
F5: In connection with, and immediately prior to, the closing of the Issuer's initial business combination, pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, the Sponsor forfeited 707,960 shares of Class B Common Stock for no consideration.
F6: The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2022 Filed Nov 18, 2022 18:04 UTC | SLR Investment Corp. SLRC · Entity 5226 | SaleCommon Stock | 3,000 | $14.01 | $42,038.10 |
DisclosureSEC source: 0000899243-22-036419 · doc4.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,742 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reported price for the share sales made on November 16, 2022 is based on prices ranging from a low of $13.9700 per share to a high of $14.0700 per share. The reporting person undertakes to provide to SLR Investment Corp. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth above. Read SEC document |
| November 16, 2022 Filed May 24, 2023 16:05 UTC Amendment | SLR Investment Corp. SLRC · Entity 5226 | SaleCommon Stock | 3,000 | $14.01 | $42,038.10 |
DisclosureSEC source: 0000899243-23-013794 · doc4a.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,742 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reported price for the share sales made on November 16, 2022 is based on prices ranging from a low of $13.9700 per share to a high of $14.0700 per share. The reporting person undertakes to provide to SLR Investment Corp. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth above. F2 · balance_after: This amendment to the Form 4 filed on November 18, 2022 is being filed to remove the disclosure of 19,258 shares of common stock of the Issuer that are held by an entity for which the reporting person is a managing trustee. Such shares were previously included in the Form 4 filed on November 18, 2022 by the reporting person but were not required to be included in the Form 4 filed on November 18, 2022 because the reporting person has no pecuniary interest in the 19,258 shares held by the entity for which the reporting person is a managing trustee. The reporting person is not deemed the beneficial owner of the securities held by this entity and does not need to report the securities held by this entity on his beneficial ownership reports. No other changes are being made hereby. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 19:25 UTC | SLR Investment Corp. SLRC · Entity 5226 | PurchaseCommon Stock | 7,400 | $14.39 | $106,461.58 |
DisclosureSEC source: 0000899243-22-035938 · doc4.xml · nonDerivative · entry 2 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 19,258 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions. The reported price for the share purchases made on November 11, 2022 is based on prices ranging from a low of $13.3600 per share to a high of $14.4000 per share. The reporting person undertakes to provide to SLR Investment Corp. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth above. F2 · ownership.nature: 19,258 shares of common stock of the Issuer are held by an entity for which the reporting person is a managing trustee. The reporting person has no pecuniary interest in the 19,258 shares held by the entity for which the reporting person is a managing trustee. Read SEC document |
| November 10, 2022 Filed Nov 10, 2022 20:16 UTC | SLR Investment Corp. SLRC · Entity 5226 | PurchaseCommon Stock | 6,858 | $13.98 | $95,840.55 |
DisclosureSEC source: 0000899243-22-035582 · doc4.xml · nonDerivative · entry 2 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 11,858 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions. The reported price for the share purchases made on November 10, 2022 is based on prices ranging from a low of $13.9340 per share to a high of $14.0000 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth above. F3 · ownership.nature: 11,858 shares of common stock of the Issuer are held by an entity for which the reporting person is a managing trustee. The reporting person has no pecuniary interest in the 11,858 shares held by the entity for which the reporting person is a managing trustee. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 20:16 UTC | SLR Investment Corp. SLRC · Entity 5226 | SaleCommon Stock | 14,850 | $13.71 | $203,663.30 |
DisclosureSEC source: 0000899243-22-035582 · doc4.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,742 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions. The reported price for the share purchases made on November 8, 2022 is based on prices ranging from a low of $13.6300 per share to a high of $13.8000 per share. The reporting person undertakes to provide to SLR Investment Corp. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth above. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 19:37 UTC | SLR Senior Investment Corp. SUNS · Entity 128277 | Disposition to issuerCommon Stock | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-013898 · doc4.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger, dated as of December 1, 2021 (the "Merger Agreement"), by and among SLR Investment Corp. ("SLRC"), SLR Senior Investment Corp. ("SUNS"), Solstice Merger Sub, Inc. and SLR Capital Partners, LLC (for the limited purposes set forth therein), in exchange for 15,592 shares of common stock, par value $0.01 per share, of SLRC. Pursuant to the Merger Agreement, each share of SUNS's common stock, par value $0.01 per share, was converted into the right to receive 0.7796 shares of SLRC's common stock. The disposition reported in this Form 4 is an exempt transaction. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 19:36 UTC | SLR Investment Corp. SLRC · Entity 5226 | GrantCommon Stock | 15,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-013896 · doc4.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,592 F1 · price: Acquired upon the completion of and pursuant to the transactions contemplated by the Agreement and Plan of Merger, dated as of December 1, 2021 (the "Merger Agreement"), by and among SLR Investment Corp. ("SLRC"), SLR Senior Investment Corp. ("SUNS"), Solstice Merger Sub, Inc. and SLR Capital Partners, LLC (for the limited purposes set forth therein), in exchange for 20,000 shares of common stock, par value $0.01 per share, of SUNS. Pursuant to the Merger Agreement, each share of SUNS's common stock was converted into the right to receive 0.7796 shares of SLRC's common stock, par value $0.01 per share. The acquisition reported in this Form 4 is an exempt transaction. Read SEC document |
| April 01, 2022 Filed Aug 18, 2022 16:05 UTC Amendment | SLR Investment Corp. SLRC · Entity 5226 | GrantCommon Stock | 15,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-029150 · doc4a.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,592 F1 · price: Acquired upon the completion of and pursuant to the transactions contemplated by the Agreement and Plan of Merger, dated as of December 1, 2021 (the "Merger Agreement"), by and among SLR Investment Corp. ("SLRC"), SLR Senior Investment Corp. ("SUNS"), Solstice Merger Sub, Inc. and SLR Capital Partners, LLC (for the limited purposes set forth therein), in exchange for 20,000 shares of common stock, par value $0.01 per share, of SUNS. Pursuant to the Merger Agreement, each share of SUNS's common stock, was converted into the right to receive 15,592 shares of SLRC's common stock, par value $0.01 per share. The acquisition reported in this Form 4 is an exempt transaction. F2 · balance_after: This amendment to the Form 4 filed on April 5, 2022 is being filed to correct a typographical error in Column 5 of Table 1, which previously inadvertently included an incorrect total amount of securities beneficially owned directly by the reporting person. No other changes are being made hereby. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 18:22 UTC | CareMax, Inc. CMAX · Entity 87127 | OtherPrivate Placement Warrants · Derivative | 2,916,667 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001193805-22-000345 · e621360_4-hochberg.xml · derivative · entry 3 HOCHBERG STEVEN · CIK 0001034123 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Through DFHTA Sponsor LLC Disclosed balance after: 0 Underlying: Class A common stock · 2,916,667 shares Expires 2026-06-08 F1 · kind: On February 11, 2022, DFHTA Sponsor LLC (the "Sponsor") distributed 3,768,750 shares of the Issuer's Class A common stock and 2,916,667 Private Placement Warrants to its members, on a pro rata basis for no consideration, in connection with the dissolution of the Sponsor. F2 · ownership.direct: The Sponsor was the record holder of the securities reported herein as being held through the Sponsor. Mr. Hochberg is a manager of the Sponsor and shared voting and investment discretion with respect to the common stock held of record by the Sponsor. Mr. Hochberg disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 18:22 UTC | CareMax, Inc. CMAX · Entity 87127 | OtherClass A common stock | 3,768,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-22-000345 · e621360_4-hochberg.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Through DFHTA Sponsor LLC Disclosed balance after: 0 F1 · kind: On February 11, 2022, DFHTA Sponsor LLC (the "Sponsor") distributed 3,768,750 shares of the Issuer's Class A common stock and 2,916,667 Private Placement Warrants to its members, on a pro rata basis for no consideration, in connection with the dissolution of the Sponsor. F2 · ownership.direct: The Sponsor was the record holder of the securities reported herein as being held through the Sponsor. Mr. Hochberg is a manager of the Sponsor and shared voting and investment discretion with respect to the common stock held of record by the Sponsor. Mr. Hochberg disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:36 UTC | Starling Oncology, Inc. DFPH · Entity 5327 | OtherPrivate Placement Warrants · Derivative | 3,177,543 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001193805-21-001591 · e621087_4-dfp.xml · derivative · entry 4 DFP Sponsor LLC · CIK 0001806360 · 10% owner · Possible Members of 10% Group HOCHBERG STEVEN · CIK 0001034123 · 10% owner · Possible Members of 10% Group Atinsky Lawrence · CIK 0001674477 · 10% owner · Possible Members of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,177,543 Underlying: Class A Common Stock · 3,177,543 shares Expires 2026-11-12 F6 · kind: The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%. F6 · price: The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%. F6 · derivative.underlying_shares: The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%. F6 · balance_after: The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%. F2 · ownership.direct: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor. F3 · ownership.direct: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:36 UTC | Starling Oncology, Inc. DFPH · Entity 5327 | ConversionClass B Common Stock · Derivative | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-21-001591 · e621087_4-dfp.xml · derivative · entry 3 DFP Sponsor LLC · CIK 0001806360 · 10% owner · Possible Members of 10% Group HOCHBERG STEVEN · CIK 0001034123 · 10% owner · Possible Members of 10% Group Atinsky Lawrence · CIK 0001674477 · 10% owner · Possible Members of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 40 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date. F1 · kind: Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration. F4 · derivative.exercise_date: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date. F4 · derivative.expiration_date: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date. F2 · ownership.direct: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor. F3 · ownership.direct: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:36 UTC | Starling Oncology, Inc. DFPH · Entity 5327 | OtherClass B Common Stock · Derivative | 707,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-21-001591 · e621087_4-dfp.xml · derivative · entry 2 DFP Sponsor LLC · CIK 0001806360 · 10% owner · Possible Members of 10% Group HOCHBERG STEVEN · CIK 0001034123 · 10% owner · Possible Members of 10% Group Atinsky Lawrence · CIK 0001674477 · 10% owner · Possible Members of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40 Underlying: Class A Common Stock · 707,960 shares Expires not disclosed F4 · derivative.exercise_price: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date. F5 · kind: In connection with, and immediately prior to, the closing of the Issuer's initial business combination, pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, the Sponsor forfeited 707,960 shares of Class B Common Stock for no consideration. F4 · derivative.exercise_date: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date. F4 · derivative.expiration_date: The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date. F2 · ownership.direct: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor. F3 · ownership.direct: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:36 UTC | Starling Oncology, Inc. DFPH · Entity 5327 | ConversionClass A Common Stock | 40 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193805-21-001591 · e621087_4-dfp.xml · nonDerivative · entry 1 DFP Sponsor LLC · CIK 0001806360 · 10% owner · Possible Members of 10% Group HOCHBERG STEVEN · CIK 0001034123 · 10% owner · Possible Members of 10% Group Atinsky Lawrence · CIK 0001674477 · 10% owner · Possible Members of 10% Group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration. F1 · price: Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration. F2 · ownership.direct: This Form 4 is being filed by DFP Sponsor, LLC (the "Sponsor"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor. F3 · ownership.direct: In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:46 UTC | CareMax, Inc. CMAX · Entity 87127 | GrantPrivate Placement Warrants · Derivative | 2,916,667 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001193805-21-000840 · e620697_4-hochberg.xml · derivative · entry 6 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Through DFHTA Sponsor LLC Disclosed balance after: 2,916,667 Underlying: Class A common stock · 2,916,667 shares Expires 2026-06-08 F5 · kind: DFHTA Sponsor LLC acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on July 21, 2020. As a result of the closing of the Business Combination, the Private Placement Warrants will become exercisable as of the date that is 12 months after the closing of the Issuer's initial public offering (i.e., July 21, 2021). The Private Placement Warrants will expire on June 8, 2026 or earlier upon redemption or liquidation. F2 · ownership.direct: DFHTA Sponsor LLC is the record holder of the shares held indirectly by the Reporting Person. Mr. Hochberg is a manager of DFHTA Sponsor LLC and shares voting and investment discretion with respect to the common stock held of record by DFHTA Sponsor LLC. Mr. Hochberg disclaims any beneficial ownership of the securities held by DFHTA Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Mr. Hochberg previously served as chief executive officer of the Issuer and, until immediately following consummation of the Business Combination, a member of the Issuer's board of directors. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:46 UTC | CareMax, Inc. CMAX · Entity 87127 | Exercise / conversionClass B common stock · Derivative | 3,368,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193805-21-000840 · e620697_4-hochberg.xml · derivative · entry 5 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Through DFHTA Sponsor LLC Disclosed balance after: 0 Underlying: Class A common stock · 3,368,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F3 · kind: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F3 · price: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F3 · derivative.exercise_date: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F3 · derivative.expiration_date: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F2 · ownership.direct: DFHTA Sponsor LLC is the record holder of the shares held indirectly by the Reporting Person. Mr. Hochberg is a manager of DFHTA Sponsor LLC and shares voting and investment discretion with respect to the common stock held of record by DFHTA Sponsor LLC. Mr. Hochberg disclaims any beneficial ownership of the securities held by DFHTA Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Mr. Hochberg previously served as chief executive officer of the Issuer and, until immediately following consummation of the Business Combination, a member of the Issuer's board of directors. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:46 UTC | CareMax, Inc. CMAX · Entity 87127 | Exercise / conversionClass B common stock · Derivative | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193805-21-000840 · e620697_4-hochberg.xml · derivative · entry 4 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A common stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F3 · kind: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F3 · price: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F3 · derivative.exercise_date: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F3 · derivative.expiration_date: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F4 · ownership.direct: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:46 UTC | CareMax, Inc. CMAX · Entity 87127 | Exercise / conversionClass A common stock | 3,368,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-21-000840 · e620697_4-hochberg.xml · nonDerivative · entry 3 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Through DFHTA Sponsor LLC Disclosed balance after: 3,768,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F2 · ownership.direct: DFHTA Sponsor LLC is the record holder of the shares held indirectly by the Reporting Person. Mr. Hochberg is a manager of DFHTA Sponsor LLC and shares voting and investment discretion with respect to the common stock held of record by DFHTA Sponsor LLC. Mr. Hochberg disclaims any beneficial ownership of the securities held by DFHTA Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Mr. Hochberg previously served as chief executive officer of the Issuer and, until immediately following consummation of the Business Combination, a member of the Issuer's board of directors. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:46 UTC | CareMax, Inc. CMAX · Entity 87127 | Exercise / conversionClass A common stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193805-21-000840 · e620697_4-hochberg.xml · nonDerivative · entry 2 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock. F4 · ownership.direct: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 17:46 UTC | CareMax, Inc. CMAX · Entity 87127 | GrantClass A common stock | 400,000 | $10.00 | $4,000,000.00 |
DisclosureSEC source: 0001193805-21-000840 · e620697_4-hochberg.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner · Director by Deputization 10b5-1 filing: Not disclosed Ownership: Indirect · Through DFHTA Sponsor LLC Disclosed balance after: 400,000 F1 · kind: On June 8, 2021, immediately prior to, and conditioned upon the consummation of, CareMax, Inc.'s (formerly known as Deerfield Healthcare Technology Acquisitions Corp.) (the "Issuer") business combination with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC (the "Business Combination"), DFHTA Sponsor LLC acquired from the Issuer 400,000 shares of Class A common stock of the Issuer. F2 · ownership.direct: DFHTA Sponsor LLC is the record holder of the shares held indirectly by the Reporting Person. Mr. Hochberg is a manager of DFHTA Sponsor LLC and shares voting and investment discretion with respect to the common stock held of record by DFHTA Sponsor LLC. Mr. Hochberg disclaims any beneficial ownership of the securities held by DFHTA Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Mr. Hochberg previously served as chief executive officer of the Issuer and, until immediately following consummation of the Business Combination, a member of the Issuer's board of directors. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 13:35 UTC | SLR Investment Corp. SLRC · Entity 5226 | SaleCommon Stock | 15,000 | $20.57 | $308,608.50 |
DisclosureSEC source: 0000899243-19-027340 · doc4.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.53 to $20.61, inclusive. The Reporting Person undertakes to provide to Solar Capital Ltd. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Following the transaction reported herein, 5,000 shares of common stock of the Issuer were held by an entity for which the reporting person is a co-trustee. In addition, 5,000 shares of common stock of the Issuer were held by an entity for which the reporting person is a managing trustee. The reporting person has no pecuniary interest in the 5,000 shares held by the entity for which the reporting person is a managing trustee. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:04 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherPrivate Placement Warrant · Derivative | 1,690,000 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0001104659-19-063525 · a4.xml · derivative · entry 3 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,643,333 Underlying: Common Stock · 1,690,000 shares Expires 2024-11-08 F3 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F3 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F4 · ownership.nature: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:04 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherClass A Common Stock | 2,373,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063525 · a4.xml · nonDerivative · entry 2 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,672,500 F3 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F3 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F4 · ownership.nature: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:04 UTC | AdaptHealth Corp. AHCO · Entity 5183 | OtherClass A Common Stock | 6,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-063525 · a4.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · kind: On November 8, 2019, in connection with (and immediately prior to) the consummation of the Issuer's initial business combination, Steven Hochberg transferred to AdaptHealth Holdings, LLC and certain of its equityholders and employees shares of the Issuer's common stock for no consideration. F2 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P. Read SEC document |
| December 14, 2018 Filed Dec 17, 2018 18:47 UTC | SLR Investment Corp. SLRC · Entity 5226 | PurchaseCommon Stock | 5,000 | $20.35 | $101,752.50 |
DisclosureSEC source: 0000899243-18-031253 · doc4.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions. The reported price for the share purchases made on December 14, 2018 is based on prices ranging from a low of $20.31 per share to a high of $20.39 per share. The reporting person undertakes to provide to Solar Capital Ltd. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth above. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 16:58 UTC | AdaptHealth Corp. DFBH · Entity 5183 | OtherCommon Stock | 921,848 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-022203 · a4.xml · nonDerivative · entry 2 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,045,652 F3 · kind: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's Registration Statement. F3 · price: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's Registration Statement. F2 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P. F4 · ownership.nature: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by the Reporting Person, as manager of Deerfield/RAB Ventures, LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 16:58 UTC | AdaptHealth Corp. DFBH · Entity 5183 | OtherCommon Stock | 3,913 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-18-022203 · a4.xml · nonDerivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,087 F1 · kind: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376) (the "Registration Statement"). F1 · price: 3,913 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376) (the "Registration Statement"). F2 · balance_after: The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the securities for the benefit, and at the direction, of Deerfield Management Company, L.P. Read SEC document |
| February 21, 2018 Filed Feb 23, 2018 17:30 UTC | AdaptHealth Corp. DFBH · Entity 5183 | PurchasePrivate Placement Warrant · Derivative | 4,333,333 | $1.50 Strike: $11.50 | $6,499,999.50 |
DisclosureSEC source: 0001104659-18-011751 · a4.xml · derivative · entry 1 HOCHBERG STEVEN · CIK 0001034123 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,333,333 Underlying: Common Stock · 4,333,333 shares Expires not disclosed F1 · derivative.exercise_date: The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or February 21, 2019. F2 · derivative.expiration_date: The warrants expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation. F3 · ownership.nature: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by the Reporting Person, as manager of Deerfield/RAB Ventures, LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.